Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Diphenhydramine × Other × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 4 Tumor-Agnostic 3 Thoracic 2 Other hematologic neoplasm 2 Lymphoid 2 Other 1 Genitourinary 1

Conditions

Stomatitis 1 Neoplasms 1 Mucositis 1

Interventions

naloxegol 7 alvimopan 6 Radiotherapy 4 tegaserod 3 angiotensin I (1-7) 3 Injections 3 Cisplatin 3 RRx-001 2 tempol 1 prucalopride 1 oxycodone naloxone combination 1 naldemedine 1 methylnaltrexone 1 linaclotide 1 licogliflozin 1 hydrated silica gel-based toothpaste 1 brilacidin 1 apraglutide 1 aluminum hydroxide, magnesium hydroxide, drug combination 1 Xylitol 1 Water 1 Therapeutics 1 Testosterone Propionate 1 Robotic Surgical Procedures 1 Radiotherapy, Intensity-Modulated 1 Phenylephrine 1 Oxycodone 1 Naloxone 1 Lubiprostone 1 Lidocaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02606994 2019-02-06

TPvsM

Oral Defense, LLC

Phase 2 Terminated

Neoplasms, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡